In a recent interview, Dr. Christopher Hurt discussed three studies (HPTN067, the U.S. PrEP Demonstration Project and ATN110) that demonstrate the feasibility of wide-scale implementation of pre-exposure prophylaxis in the United States.
It's about a real-life response to AIDS - a fierce commitment to creating and translating knowledge that advances the fight against HIV & AIDS
